Literature DB >> 2628734

Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element.

G A Brent1, J W Harney, Y Chen, R L Warne, D D Moore, P R Larsen.   

Abstract

We have previously identified sequences required for thyroid hormone (T3) induction of the rat GH (rGH) promoter, which lie in a region from -188 to -164 upstream of the mRNA start site. Within this region, Domains A, -189 to -184 and B, -179 to -174, are imperfect direct repeats, and domain C, -172 to -167, is a divergent inverted copy that matches the A domain at 4/6 positions. A series of synthetic mutant versions of this sequence were inserted upstream of a truncated rGH promoter, or as a replacement for wild-type sequences in a synthetic 237 base pair rGH promoter or upstream of the heterologous thymidine kinase promoter. Mutations changing the B domain to a perfect copy of the A domain significantly increased T3 induction (21.3-fold) relative to the wild type (3.6-fold). A single point mutation making the C domain a better match to the A domain also increased T3 induction to 16.2-fold. Combining this up-mutation with any of three down-mutations in the A, B, or C domains strongly decreased response, showing that all three domains contribute to the amplified T3 response. Binding affinity of the various mutant oligonucleotides was assessed using in vitro translated receptor and affinity paralleled the functional responses for most binding site mutations. Requirements for in vitro binding were, however, less rigorous than those for functional T3 induction. Based on these results, we propose a consensus T3 receptor binding half-site, AGGT(C/A)A, at least two copies of which are required for a T3 response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628734     DOI: 10.1210/mend-3-12-1996

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Molecular and phenotypic analysis of 25 recessive, homozygous-viable alleles at the mouse agouti locus.

Authors:  Rosalynn J Miltenberger; Kazumasa Wakamatsu; Shosuke Ito; Richard P Woychik; Liane B Russell; Edward J Michaud
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

Review 2.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 3.  The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development.

Authors:  George Mastorakos; Eftychia I Karoutsou; Maria Mizamtsidi; George Creatsas
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

4.  Nuclear assembly of UGA decoding complexes on selenoprotein mRNAs: a mechanism for eluding nonsense-mediated decay?

Authors:  Lucia A de Jesus; Peter R Hoffmann; Tanya Michaud; Erin P Forry; Andrea Small-Howard; Robert J Stillwell; Nadya Morozova; John W Harney; Marla J Berry
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor.

Authors:  M A Lazar; T J Berrodin; H P Harding
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  Thyroid hormone stimulates the renal Na/H exchanger NHE3 by transcriptional activation.

Authors:  A Cano; M Baum; O W Moe
Journal:  Am J Physiol       Date:  1999-01

7.  Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription.

Authors:  E J Schwarz; M J Reginato; D Shao; S L Krakow; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Regulation of the mdm2 oncogene by thyroid hormone receptor.

Authors:  J S Qi; Y Yuan; V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Novel mechanism of positive versus negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver.

Authors:  Preeti Ramadoss; Brian J Abraham; Linus Tsai; Yiming Zhou; Ricardo H Costa-e-Sousa; Felix Ye; Martin Bilban; Keji Zhao; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

10.  Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme.

Authors:  D Salvatore; S C Low; M Berry; A L Maia; J W Harney; W Croteau; D L St Germain; P R Larsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.